Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 Aug;61(8):3209–3215. doi: 10.1128/iai.61.8.3209-3215.1993

Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin.

R I Roth 1, F C Levin 1, J Levin 1
PMCID: PMC280989  PMID: 8335351

Abstract

Bacterial endotoxin (lipopolysaccharide [LPS]) is known to interact with numerous components of blood, including erythrocytes, mononuclear cells, platelets, neutrophils, lipoproteins, and plasma proteins. The relative affinities of LPS for these elements, and the distribution of LPS between them, are unknown. Cross-linked stroma-free hemoglobin (SFH), a potential substitute for erythrocyte transfusion, produces in vivo toxicity in animals consistent with significant LPS contamination. Therefore, we studied the distribution of LPS in human and rabbit blood and examined whether the presence of SFH altered LPS distribution. In either the presence or absence of SFH, LPS was associated predominantly with high-density lipoproteins and apoproteins. There was lesser binding to low- and very-low-density lipoproteins. Examination of the apoprotein pool by column chromatography and density centrifugation demonstrated that LPS in this fraction was predominantly protein bound. Binding of LPS to SFH resulted in dissociation of a portion of the LPS into low-molecular-weight complexes. Cell-bound LPS was only 2 to 16% of the total and was unaffected by SFH. The distribution among blood cells demonstrated predominant binding to platelets in human blood but predominant binding to erythrocytes in rabbit blood. Cellular distribution was not significantly altered by SFH.

Full text

PDF
3209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAUDE A. I., CAREY F. J., ZALESKY M. Studies with radioactive endotoxin. II. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with radioactive sodium chromate. J Clin Invest. 1955 Jun;34(6):858–866. doi: 10.1172/JCI103141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRUNNING R. D., WOOLFREY B. F., SCHRADER W. H. STUDIES WITH TRITIATED ENDOTOXIN. II. ENDOTOXIN LOCALIZATION IN THE FORMED ELEMENTS OF THE BLOOD. Am J Pathol. 1964 Mar;44:401–409. [PMC free article] [PubMed] [Google Scholar]
  3. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  4. Brandtzaeg P., Bryn K., Kierulf P., Ovstebø R., Namork E., Aase B., Jantzen E. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest. 1992 Mar;89(3):816–823. doi: 10.1172/JCI115660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooper N. R., Morrison D. C. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol. 1978 Jun;120(6):1862–1868. [PubMed] [Google Scholar]
  6. DES PREZ R. M., HOROWITZ H. I., HOOK E. W. Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro. J Exp Med. 1961 Dec 1;114:857–874. doi: 10.1084/jem.114.6.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A., Jr, O'Connor J. V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986 Jun 1;163(6):1433–1450. doi: 10.1084/jem.163.6.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eichbaum E. B., Harris H. W., Kane J. P., Rapp J. H. Chylomicrons can inhibit endotoxin activity in vitro. J Surg Res. 1991 Nov;51(5):413–416. doi: 10.1016/0022-4804(91)90143-a. [DOI] [PubMed] [Google Scholar]
  9. Evatt B. L., Levin J. Measurement of thrombopoiesis in rabbits using 75selenomethionine. J Clin Invest. 1969 Sep;48(9):1615–1626. doi: 10.1172/JCI106127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feola M., Simoni J., Canizaro P. C. Quality control of hemoglobin solutions. I. The purity of hemoglobin before modification. Artif Organs. 1991 Jun;15(3):243–248. [PubMed] [Google Scholar]
  11. Feola M., Simoni J., Canizaro P. C., Tran R., Raschbaum G., Behal F. J. Toxicity of polymerized hemoglobin solutions. Surg Gynecol Obstet. 1988 Mar;166(3):211–222. [PubMed] [Google Scholar]
  12. Freudenberg M. A., Bøg-Hansen T. C., Back U., Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun. 1980 May;28(2):373–380. doi: 10.1128/iai.28.2.373-380.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Freudenberg M. A., Meier-Dieter U., Staehelin T., Galanos C. Analysis of LPS released from Salmonella abortus equi in human serum. Microb Pathog. 1991 Feb;10(2):93–104. doi: 10.1016/0882-4010(91)90070-q. [DOI] [PubMed] [Google Scholar]
  14. Galanos C., Rietschel E. T., Lüderitz O., Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem. 1971 Mar 1;19(1):143–152. doi: 10.1111/j.1432-1033.1971.tb01298.x. [DOI] [PubMed] [Google Scholar]
  15. Galanos C., Rietschel E. T., Lüderitz O., Westphal O., Kim Y. B., Watson D. W. Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem. 1972 Dec 4;31(2):230–233. doi: 10.1111/j.1432-1033.1972.tb02524.x. [DOI] [PubMed] [Google Scholar]
  16. Ginsberg M. H., Morrison D. C. The selective binding of aggregated IgG to lipid A-rich bacterial lipopolysaccharides. J Immunol. 1978 Jan;120(1):317–319. [PubMed] [Google Scholar]
  17. Greisman S. E., Hornick R. B. Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin. Proc Soc Exp Biol Med. 1969 Sep;131(4):1154–1158. doi: 10.3181/00379727-131-34059. [DOI] [PubMed] [Google Scholar]
  18. HERRING W. B., HERION J. C., WALKER R. I., PALMER J. G. Distribution and clearance of circulating endotoxin. J Clin Invest. 1963 Jan;42:79–87. doi: 10.1172/JCI104698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. HOROWITZ H. I., DES PREZ R. M., HOOK E. W. Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo. J Exp Med. 1962 Nov 1;116:619–633. doi: 10.1084/jem.116.5.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harris H. W., Grunfeld C., Feingold K. R., Rapp J. H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990 Sep;86(3):696–702. doi: 10.1172/JCI114765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Levin J., Bang F. B. Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh. 1968 Mar 31;19(1):186–197. [PubMed] [Google Scholar]
  22. Lorenzet R., Niemetz J., Marcus A. J., Broekman M. J. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J Clin Invest. 1986 Aug;78(2):418–423. doi: 10.1172/JCI112592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mathison J. C., Ulevitch R. J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol. 1979 Nov;123(5):2133–2143. [PubMed] [Google Scholar]
  24. Maxie M. G., Valli V. E., Robinson G. A., Truscott R. B., McSherry B. J. Studies with radioactive endotoxin. I. Clearance of 51Cr-labelled endotoxin from the blood of calves. Can J Comp Med. 1974 Oct;38(4):347–366. [PMC free article] [PubMed] [Google Scholar]
  25. Maxie M. G., Valli V. E. Studies with radioactive endotoxin. III. Localization of 3H-labelled endotoxin in the formed elements of the blood and detection of endotoxin in calf blood with the Limulus amebocyte lysate. Can J Comp Med. 1974 Oct;38(4):383–390. [PMC free article] [PubMed] [Google Scholar]
  26. Michie H. R., Manogue K. R., Spriggs D. R., Revhaug A., O'Dwyer S., Dinarello C. A., Cerami A., Wolff S. M., Wilmore D. W. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988 Jun 9;318(23):1481–1486. doi: 10.1056/NEJM198806093182301. [DOI] [PubMed] [Google Scholar]
  27. Munford R. S., Hall C. L., Dietschy J. M. Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins. Infect Immun. 1981 Dec;34(3):835–843. doi: 10.1128/iai.34.3.835-843.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Munford R. S., Hall C. L., Lipton J. M., Dietschy J. M. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest. 1982 Oct;70(4):877–888. doi: 10.1172/JCI110684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nagayama M., Zucker M. B., Beller F. K. Effects of a variety of endotoxins on human and rabbit platelet function. Thromb Diath Haemorrh. 1971 Dec 31;26(3):467–473. [PubMed] [Google Scholar]
  30. Nolan J. P. Intestinal endotoxins as mediators of hepatic injury--an idea whose time has come again. Hepatology. 1989 Nov;10(5):887–891. doi: 10.1002/hep.1840100523. [DOI] [PubMed] [Google Scholar]
  31. Ohno N., Morrison D. C. Lipopolysaccharide interaction with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J Biol Chem. 1989 Mar 15;264(8):4434–4441. [PubMed] [Google Scholar]
  32. REAM V. J., DEYKIN D., GUREWICH V., WESSLER S. THE AGGREGATION OF HUMAN PLATELETS BY BACTERIAL ENDOTOXIN. J Lab Clin Med. 1965 Aug;66:245–252. [PubMed] [Google Scholar]
  33. Rabellino E. M., Nachman R. L., Williams N., Winchester R. J., Ross G. D. Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med. 1979 Jun 1;149(6):1273–1287. doi: 10.1084/jem.149.6.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rickles F. R., Levin J., Hardin J. A., Barr C. F., Conrad M. E., Jr Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response. J Lab Clin Med. 1977 Apr;89(4):792–803. [PubMed] [Google Scholar]
  35. Roth R. I., Gaubatz J. W., Gotto A. M., Jr, Patsch J. R. Effect of cholesterol feeding on the distribution of plasma lipoproteins and on the metabolism of apolipoprotein E in the rabbit. J Lipid Res. 1983 Jan;24(1):1–11. [PubMed] [Google Scholar]
  36. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. [PubMed] [Google Scholar]
  37. Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and function of lipopolysaccharide binding protein. Science. 1990 Sep 21;249(4975):1429–1431. doi: 10.1126/science.2402637. [DOI] [PubMed] [Google Scholar]
  38. Springer G. F., Adye J. C., Bezkorovainy A., Jirgensons B. Properties and activity of the lipopolysaccharide-receptor from human erythrocytes. Biochemistry. 1974 Mar 26;13(7):1379–1389. doi: 10.1021/bi00704a011. [DOI] [PubMed] [Google Scholar]
  39. Springer G. F., Huprikar S. V., Neter E. Specific inhibition of endotoxin coating of red cells by a human erythrocyte membrane component. Infect Immun. 1970 Jan;1(1):98–108. doi: 10.1128/iai.1.1.98-108.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tobias P. S., Soldau K., Ulevitch R. J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med. 1986 Sep 1;164(3):777–793. doi: 10.1084/jem.164.3.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tobias P. S., Ulevitch R. J. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). J Immunol. 1983 Oct;131(4):1913–1916. [PubMed] [Google Scholar]
  42. Tracey K. J., Vlassara H., Cerami A. Cachectin/tumour necrosis factor. Lancet. 1989 May 20;1(8647):1122–1126. doi: 10.1016/s0140-6736(89)92394-5. [DOI] [PubMed] [Google Scholar]
  43. Ulevitch R. J., Johnston A. R. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J Clin Invest. 1978 Dec;62(6):1313–1324. doi: 10.1172/JCI109252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ulevitch R. J., Johnston A. R., Weinstein D. B. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest. 1979 Nov;64(5):1516–1524. doi: 10.1172/JCI109610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ulevitch R. J. The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. Immunochemistry. 1978 Mar;15(3):157–164. doi: 10.1016/0161-5890(78)90144-x. [DOI] [PubMed] [Google Scholar]
  46. Vosbeck K., Tobias P., Mueller H., Allen R. A., Arfors K. E., Ulevitch R. J., Sklar L. A. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukoc Biol. 1990 Feb;47(2):97–104. doi: 10.1002/jlb.47.2.97. [DOI] [PubMed] [Google Scholar]
  47. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med. 1989 Dec 1;170(6):1859–1867. doi: 10.1084/jem.170.6.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weiss J., Muello K., Victor M., Elsbach P. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol. 1984 Jun;132(6):3109–3115. [PubMed] [Google Scholar]
  50. White C. T., Murray A. J., Greene J. R., Smith D. J., Medina F., Makovec G. T., Martin E. J., Bolin R. B. Toxicity of human hemoglobin solution infused into rabbits. J Lab Clin Med. 1986 Aug;108(2):121–131. [PubMed] [Google Scholar]
  51. White C. T., Murray A. J., Smith D. J., Greene J. R., Bolin R. B. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med. 1986 Aug;108(2):132–137. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES